絞り込み

16645

広告

「"Respondek G "[Author]」の検索結果

29件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Classification of atypical parkinsonism per pathology versus phenotype.

Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.

Four-repeat tauopathies.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

[Tauopathies : From molecule to therapy].

New classification of tauopathies.

Variation at the TRIM11 locus modifies Progressive Supranuclear Palsy phenotype.

Progressive supranuclear palsy and multiple system atrophy: clinicopathological concepts and therapeutic challenges.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Manual MRI morphometry in Parkinsonian syndromes.

An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.

Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice.

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.

Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.

The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.

From a single nucleotide polymorphism to tau pathology: Appoptosin is the missing link.

The phenotypic spectrum of progressive supranuclear palsy.

  1. 1
  2. 2
Sort by
※並べ替えは表示に時間がかかります